Carboplatin-image1 (Carboplatin Image1)
Carboplatin Injection, Solution
Product Images NDC 68083-192
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 68083-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carboplatin-image2 (Image2)
Carboplatin-image3 (Image3)
CARBOplatin is a cytotoxic agent that is supplied as a sterile, aqueous solution in a 45mL multi-dose vial containing 450mg/45. The usual dosage and prescribing information are available on the package insert. It should be stored at 20-25°C and protected from light. Each vial contains carboplatin USP (25 is to 10mg/mL solution in Water for Injection, USP) and contains no preservatives. This product is for intravenous use only. The remaining text is not readable.*
Carboplatin-image4 (Image4)
Carboplatin-image5 (Image5)
This is a description of a medication called Carboplatin. It comes in a Multi-Dose Vial with a concentration of 10mg/mL and a total volume of 60mL. It is a sterile, aqueous solution which is used for intravenous injections. Carboplatin is a cytotoxic agent and each vial contains 600mg of Carboplatin USP as a 10mg/mL solution in Water for Injection, USP. It is manufactured by Gland Pharma. The label indicates that it should be stored at controlled room temperature, protected from light and kept in the carton until use. The prescription carries the NDC code 6808319301. The instruction of use should be obtained from the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
